TELA Bio, Inc. (TELA) Free cash flow 2017–2025
TELA Bio, Inc. (TELA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$28.7MFY2025 · since FY2017: -$16.5M → -$28.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$28.7M | +32.7% |
| FY2024 | -$42.6M | -2.7% |
| FY2023 | -$41.5M | +0.4% |
| FY2022 | -$41.6M | -34.0% |
| FY2021 | -$31.1M | -26.1% |
| FY2020 | -$24.6M | +4.3% |
| FY2019 | -$25.7M | -28.7% |
| FY2018 | -$20.0M | -21.3% |
| FY2017 | -$16.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TELA financial trends
TELA RevenueTELA Net incomeTELA Net marginTELA Gross profitTELA Gross marginTELA Operating incomeTELA Operating marginTELA Operating cash flowTELA Capital expendituresTELA Return on equityTELA Stock buybacksTELA Dividends paidTELA Total assetsTELA Total liabilitiesTELA Shareholders’ equityTELA overview →